Family Medicine Doctors in Mariposa, CA Accepting Medicare

4 Family Medicine doctors found. Showing 1 - 4

Dr. Ravinder R. Kadevari, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 5192 Hospital Rd, Mariposa, CA 95338 Phone: 209-742-6144    Fax: 209-754-6274

Carolyn Joan Rose, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5300 Highway 49 North, Mariposa, CA 95338 Phone: 209-966-3672    Fax: 209-966-5548

Dr. Kelly Andre Sharrar, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4981 Indian Peak Rd, Mariposa, CA 95338 Phone: 209-742-5977    Fax: 209-266-1855

Mr. Robert J Rose, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5300 Highway 49 North, Mariposa, CA 95338 Phone: 209-966-3672    Fax: 209-966-5548

News Archive

Chaotic and incoherent: Damning study of over 500 U.S. campus COVID-19 reopening plans

Now, a new study by researchers at California Institute of Technology and Johns Hopkins University and published on the preprint server medRxiv* in August 2020 shows that poorly planned and inadequate testing approaches to mitigate viral spread among the returning university students are likely to result in epidemics that will plague the country for a long time.

Stephen J. Teach receives $2.2M award to study how cell phones help manage asthma in children

Stephen J. Teach, MD, MPH, Associate Chief of Emergency Medicine at Children's National Health System, says that aggressively managing parental stress and using cell phone apps to monitor medication usage in at-risk youth with asthma may improve children's adherence to asthma medications.

Scientists discover new non-genetic cause of resistance to anti-cancer therapies

The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States.

Serametrix and the Ludwig Institute for Cancer Research form a partnership

Serametrix Corporation, a personalized medicine company, today announced their partnership with the Ludwig Institute for Cancer Research Ltd. (LICR). The agreement will combine LICR's historic discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix. This new alliance will enable rapid development and commercialization of tests that predict and monitor drug response in cancer patients. The serum-based tests, which determine immune reaction to tumor antigens, are of value to clinicians and drug developers alike.

Read more Medical News

› Verified 1 days ago